| ASSET | YEAR | % RETURN |
|---|---|---|
Exxon Mobil (XOM) | 2022 | 87.3% |
Chevron (CVX) | 2022 | 58.37% |
Merck (MRK) | 2022 | 49.54% |
Eli Lilly and (LLY) | 2022 | 35.12% |
Shell PLC ADR (SHEL) | 2022 | 34.04% |
Novo Nordisk A-S (NVO) | 2022 | 25.26% |
AbbVie (ABBV) | 2022 | 24% |
T-Mobile US (TMUS) | 2022 | 20.94% |
AstraZeneca PLC ADR (AZN) | 2022 | 19.11% |
Philip Morris International (PM) | 2022 | 12.44% |
Coca-Cola (KO) | 2022 | 11.34% |
International Business Machines (IBM) | 2022 | 10.3% |
Novartis AG ADR (NVS) | 2022 | 8.22% |
PepsiCo (PEP) | 2022 | 7.72% |
UnitedHealth (UNH) | 2022 | 7.39% |
Johnson & Johnson (JNJ) | 2022 | 6.51% |
Berkshire Hathaway (BRK.A) | 2022 | 3.7% |
Berkshire Hathaway (BRK.B) | 2022 | 2.93% |
Walmart (WMT) | 2022 | 0.01% |
McDonald’s (MCD) | 2022 | -0.02% |
Mastercard (MA) | 2022 | -2.79% |
Visa Inc Class A (V) | 2022 | -3.76% |
Procter & Gamble (PG) | 2022 | -3.94% |
LIN TV (LIN) | 2022 | -4.39% |
Oracle (ORCL) | 2022 | -4.78% |
Mega-cap stocks are treated as having a market cap of $200B+.
